Atención farmacéutica a paciente de 17 años con diagnóstico de fiebre reumática utilizando como tratamiento penicilina–benzatina y ácido acetilsalicílico

Abstract

Rheumatic fever is an autoimmune disease caused by an inflammatory process of group A beta-hemolytic streptococcus. It mainly affects the heart, joints, brain and skin. The WHO has revealed causes of morbidity and mortality worldwide affecting 33 million people that caused death in vulnerable people such as children, adolescents, pregnant women and the elderly. Descriptive and analytical study techniques were implemented, with the objective of developing a program of pharmaceutical care for patients with rheumatic fever through pharmacotherapeutic follow-up, healthy lifestyle habits, to prevent or delay the onset of complications associated with the disease. A plan of pharmaceutical care is proposed in the patient to identify the problems related to the medication, justifying that he received a complete pharmacotherapy. The treatment is based on the administration of penicillin G benzathine as an antibiotic indicated to eliminate the germ, control and prevent possible reappearances of an NSAID such as aspirin for the prevention of heart attacks.